<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Massachusetts Department of Developmental Services adult screening recommendations 2012.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Massachusetts Department of Developmental Services. Massachusetts Department of Developmental Services adult screening recommendations 2012. Boston (MA): Massachusetts Department of Developmental Services; 2012. 2 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Massachusetts Department of Developmental Services. Massachusetts Department of Mental Retardation health screening recommendations. Boston (MA): Massachusetts Department of Developmental Services; 2007. 2 p.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="HCPCS: Dysphagia screening ; Hearing screening "/><FieldValue Value="ICD9CM: Bone mineral density studies  (88.98); Cardiovascular disease, unspecified  (429.2); Colonoscopy  (45.23); Complications affecting other specified body systems, not elsewhere classified, hypertension  (997.91); Comprehensive eye examination  (95.02); Comprehensive eye examination  (95.03); Diagnostic ultrasound of heart  (88.72); Digital examination of rectum  (89.34); Diphtheria, unspecified  (032.9); Dysphagia, unspecified  (787.20); General physical examination  (89.7); Hearing examination, not otherwise specified  (95.42); Hearing examination, not otherwise specified  (95.47); Malignant neoplasm of breast (female), unspecified  (174.9); Malignant neoplasm of cervix uteri, unspecified site  (180.9); Malignant neoplasm of colon, unspecified site  (153.9); Malignant neoplasm of prostate  (185); Osteoporosis, unspecified  (733.00); Other x-ray of cervical spine  (87.22); Screening for glaucoma  (V80.1); Tetanus  (037); Unspecified glaucoma  (365.9); Venereal disease, unspecified  (099.9); Whooping cough due to bordetella pertussis [B. pertussis]  (033.0)"/><FieldValue Value="MSH: Blood Pressure Determination ; Body Mass Index ; Bone Density ; Breast Self-Examination ; Cardiovascular Diseases ; Chickenpox ; Chickenpox Vaccine ; Chlamydia ; Colonoscopy ; Colorectal Neoplasms ; Counseling ; Deglutition Disorders ; Dementia ; Depression ; Diabetes Mellitus ; Diagnosis, Oral ; Diagnostic Techniques, Ophthalmological ; Digital Rectal Examination ; Diphtheria ; Diphtheria-Tetanus-acellular Pertussis Vaccines ; Echocardiography ; Glaucoma ; Hearing Disorders ; Hearing Tests ; Hemoglobin A, Glycosylated ; Hepatitis A ; Hepatitis A Vaccines ; Hepatitis B ; Hepatitis B Vaccines ; Hepatitis B Vaccines ; Hepatitis C ; Herpes Zoster ; Herpes Zoster Vaccine ; HIV ; Hypercholesterolemia ; Hypertension ; Immunization ; Immunization Programs ; Immunization Schedule ; Influenza Vaccines ; Influenza, Human ; Liver Function Tests ; Mammography ; Mass Screening ; Measles ; Measles-Mumps-Rubella Vaccine ; Mumps ; Occult Blood ; Osteoporosis ; Papillomavirus Infections ; Papillomavirus Vaccines ; Physical Examination ; Pneumococcal Vaccines ; Pneumonia ; Preventive Health Services ; Prostate-Specific Antigen ; Radiography ; Rubella ; Sexually Transmitted Diseases ; Sigmoidoscopy ; Skin Neoplasms ; Testicular Neoplasms ; Tetanus ; Thyroid Function Tests ; Tuberculin Test ; Tuberculosis ; Vaccination ; Vaginal Smears ; Vision Disorders ; Vision Screening ; Vision Tests ; Whooping Cough "/><FieldValue Value="MTH: Blood glucose measurement ; Blood pressure determination ; Body mass index procedure ; Bone Density ; Bone Mineral Density Test ; Breast Self-Examination ; Cardiovascular Diseases ; Chickenpox ; Chickenpox Vaccine ; Chlamydia ; Chlamydia antibody assay ; Colonoscopy ; Colorectal Carcinoma ; Counseling ; Deglutition Disorders ; Dementia ; Depression screen ; Diabetes Mellitus ; Digital Rectal Examination ; Diphtheria ; Echocardiography ; Encounter for screening for glaucoma ; Fecal occult blood test ; Glaucoma ; Glaucoma screening ; Glucohemoglobin measurement ; Glycosylated hemoglobin A ; Hearing problem ; Hearing Tests ; Hepatitis A ; Hepatitis A Vaccines ; Hepatitis B ; Hepatitis B Vaccines ; Hepatitis B Vaccines ; Hepatitis C ; Herpes zoster disease ; Herpes Zoster Vaccine ; HIV ; Hypercholesterolemia ; Hypertensive disease ; Immunization ; Influenza ; Influenza virus vaccine ; Liver Function Tests ; Malignant neoplasm of breast ; Malignant neoplasm of female breast ; Malignant neoplasm of prostate ; Malignant neoplasm of skin ; Malignant neoplasm of testis ; Malignant tumor of cervix ; Malignant tumor of colon ; Mammography ; Manual pelvic examination (procedure) ; Measles ; Measles-Mumps-Rubella Vaccine ; Mental Depression ; Mental Retardation ; Mumps ; Occult blood screen ; Osteoporosis ; Pap smear ; Pertussis ; physical examination ; Pneumococcal vaccine ; Pneumonia ; Prostate-Specific Antigen ; Radiographic imaging procedure ; Radiography of cervical spine ; Rubella ; Screening for cancer ; Screening for malignant neoplasm of breast ; Sexually Transmitted Diseases ; Sigmoidoscopy (procedure) ; Skin Neoplasms ; Testicular Neoplasms ; Tetanus ; Thyroid Function Tests ; Tuberculin Test ; Tuberculosis ; Vaccination ; Vision Disorders ; Vision Tests "/><FieldValue Value="PDQ: colonoscopy ; dysphagia ; fecal occult blood test ; mammography ; osteoporosis ; Pap test ; skin tumor "/><FieldValue Value="SNOMEDCT_US: Auditory testing  (252575000); Auditory testing  (32921008); Auditory testing  (398171003); Auditory testing  (398280008); Blood pressure taking  (46973005); Breast self-examination  (409979009); Chemical test for occult blood  (104435004); Chemical test for occult blood  (80556006); Chlamydia  (16241000); Colonoscopy  (73761001); Comprehensive eye examination  (78831002); Counseling  (129441002); Counseling  (409063005); Delayed hypersensitivity skin test for tuberculin PPD  (424294008); Dementia  (52448006); Depression screening  (171207006); Diabetes mellitus  (73211009); Difficulty swallowing  (288939007); Difficulty swallowing  (40739000); Digital examination of rectum  (410006001); Diphtheria  (276197005); Diphtheria  (397428000); Diphtheria + tetanus + acellular pertussis vaccine  (429321000124106); Disease due to Papilloma virus  (30415006); Disorder of cardiovascular system  (49601007); Disorder of vision  (128127008); Disorder of vision  (95677002); Echocardiography  (40701008); Examination of breast  (46662001); Examination of skin  (271303006); Fasting lipid profile  (252150008); Glaucoma  (23986001); Glaucoma screening  (171215009); Glucohemoglobin measurement  (40402000); Glucose measurement, blood  (33747003); Glycosylated hemoglobin A  (33601001); Gonorrhea infection titer test  (165829005); Hearing problem  (128540005); Hearing problem  (300228004); Hearing problem  (362966006); Hearing problem  (362989003); Hepatitis B screening test  (171122006); Hepatitis B screening test  (314099008); Hepatitis C screening  (413107006); Hepatitis non-A non-B  (186634008); Hepatitis non-A non-B  (50711007); Herpes zoster  (4740000); Human immunodeficiency virus  (19030005); Hypercholesterolemia  (13644009); Hypertensive disorder  (38341003); Immunization  (127785005); Influenza  (6142004); Influenza virus vaccine  (396425006); Influenza virus vaccine  (46233009); Liver function tests - general  (26958001); Liver function tests - general  (271552009); Malignant neoplasm of female breast  (372064008); Malignant neoplasm of skin  (372130007); Malignant tumor of breast  (254837009); Malignant tumor of cervix  (363354003); Malignant tumor of colon  (363406005); Malignant tumor of prostate  (399068003); Malignant tumor of testis  (363449006); Mammography  (71651007); Manual pelvic examination  (35025007); Measles  (14189004); Measles, mumps and rubella vaccine  (396429000); Measles, mumps and rubella vaccine  (61153008); Measurement of Chlamydia antibody  (104281002); Mental retardation  (91138005); Mumps  (240526004); Mumps  (36989005); Neoplasm of large intestine  (126837005); Neoplasm of skin  (126488004); Neoplasm of testis  (126900000); Occult blood screening  (252156002); Osteoporosis  (64859006); Pertussis  (27836007); Physical assessment  (302199004); Physical assessment  (5880005); Physical assessment  (81375008); Pneumococcal vaccine  (333598008); Pneumococcal vaccine  (398730001); Pneumonia  (233604007); Prostate specific antigen  (102687007); Radiographic imaging procedure  (363680008); Radiography of cervical spine  (66769009); Rubella  (36653000); Screening for cancer  (15886004); Screening for cardiovascular system disease  (300007000); Screening for dysphagia  (431765005); Screening for malignant neoplasm of breast  (268547008); Sexually transmitted infectious disease  (8098009); Sigmoidoscopy  (24420007); Tetanus  (276202003); Tetanus  (76902006); Thyroid panel  (35650009); Tuberculosis  (371569005); Tuberculosis  (373576009); Tuberculosis  (56717001); Type B viral hepatitis  (66071002); Varicella  (38907003); Varicella virus vaccine  (108729007); Varicella virus vaccine  (396442000); Viral hepatitis, type A  (40468003); Vision screening  (408760009); Visual testing  (268360001)"/><FieldValue Value="UMD: Radiographic Systems  (18-429); Scanning Systems, Ultrasonic, Cardiac  (17-422)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Intellectual disability, learning disability, mental retardation, including Down syndrome &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cancer (breast, cervical, colorectal, testicular, prostate, and skin) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Infectious diseases (sexually transmitted diseases; human immunodeficiency virus [HIV]; hepatitis A, B, and C; tuberculosis; influenza; pneumonia; tetanus; diphtheria; pertussis; measles; mumps; rubella; human papillomavirus infection; varicella; shingles) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hypertension &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hypercholesterolemia &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Diabetes &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Dysphagia and aspiration &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cardiovascular disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Osteoporosis &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hearing and vision impairments, including glaucoma &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Depression &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Dementia &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Prevention" /><FieldValue Value="Screening" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Family Practice" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Preventive Medicine" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Health Care Providers" /><FieldValue Value="Patients" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To present preventive health recommendations for adults with intellectual or developmental disability (mental retardation)&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Adults (&amp;ge;19 years of age) with intellectual or developmental disability (mental retardation)&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Screening&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Cancer Screening&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Breast mammography with clinical breast exam and self-examination instruction, as appropriate &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pelvic examination and pap smear &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Fecal occult blood testing (FOBT) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Sigmoidoscopy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Colonoscopy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clinical testicular examination &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Digital rectal exam (DRE) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Prostate specific antigen (PSA) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Skin examination &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Other Screening&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Body mass index (BMI) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Blood pressure &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Blood lipid levels &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Blood glucose or glycosylated hemoglobin (HgbA1c) levels &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Liver function tests &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Dysphagia and aspiration screening &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cardiovascular disease screening &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Bone mineral density (BMD) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hearing assessment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Comprehensive eye exam &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Glaucoma assessment &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Infectious Disease Screening&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Chlamydia and gonorrhea screening &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Human immunodeficiency virus (HIV) screening &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hepatitis B and C screening &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Tuberculin skin testing &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Mental and Behavioral Health Screening&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Depression assessment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Dementia assessment &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Screening for Persons with Down Syndrome&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Thyroid function test &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cervical spine x-ray &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Echocardiogram &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Prevention&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Health maintenance visit &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Oral health visit &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Immunizations for:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Influenza &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Pneumococcal pneumonia &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Hepatitis B and A &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Tetanus, diphtheria, pertussis (TdaP) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Measles, mumps, and rubella (MMR) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Human papillomavirus (HPV) infection &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Varicella &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Zoster virus infection (shingles) &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;General counseling and guidance &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Comprehensive review of available Medline/PubMed sources, comparison to general population screening measures (Massachusetts Quality Health Partnerships), materials developed by advocacy and state agencies&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;20+&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Expert Consensus (Committee)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Literature review using structured evaluation of strength of evidence. Consensus review with expert clinical panel (see the &quot;Description of Methods Used to Formulate the Recommendations&quot; field).&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The development of the recommendations required careful consideration of many elements in the lives of adults with intellectual disabilities.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Phase I&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Committee members received a package of reference material for review prior to the initial meeting. Members reviewed the general findings from the literature search and discussed their own professional experience in community care for people with intellectual disabilities. Following discussion, committee members agreed to adopt generally accepted &lt;em&gt;Massachusetts Health Quality Partners (MHQP)&lt;/em&gt; guidelines for the general population as a baseline and develop recommendations for modifications to address areas of greater concern for the population of people with intellectual disabilities.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Based on findings in the literature and the experience of committee members, three focus areas emerged:&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;The need to review and modify generic MHQP standards to ensure they are appropriate to the health needs of the adult population with intellectual disability. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The need to facilitate effective communication relating to an individual's health, lifestyle, adaptive functioning, and service plan between residential staff or family members and the community clinician. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The need to consider additional recommendations for sub-populations such as those with identifiable syndromes or comorbid conditions that are associated with additional health risks. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;The committee formed three sub-groups and each group was charged with developing recommendations to address one of the above areas.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Phase II&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Subcommittees met to develop recommendations that were shared at a second Advisory Committee meeting. The entire Advisory Committee reviewed and commented on the work of each subcommittee. The subcommittees then formed their final recommendations.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Phase III&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The final meeting and discussion of the Advisory Committee was held for discussion of the remaining work of each committee. Subcommittee members agreed to complete recommendations for the final report to be forwarded to the Department of Mental of Retardation (name changed to Department of Developmental Services as of July 1, 2009).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;These recommendations were revised in October 2005, July 2007, February 2010, and February 2012.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Final committee recommendations were sent to qualified individuals in the field for review and comment. Minor modifications were made to recommendations based on this review.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Note&lt;/strong&gt;: Items that are indicated in &lt;strong&gt;&lt;em&gt;Bold Italic&lt;/em&gt;&lt;/strong&gt; are specific recommendations that differ from the Massachusetts Health Quality Partnership (MHQP) recommendations in order to reflect particular health concerns of the population with intellectual disability.&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;3&quot; cellpadding=&quot;5&quot; summary=&quot;Table: Health screening recommendations&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th width=&quot;15%&quot; valign=&quot;top&quot;&gt;Procedure&lt;/th&gt;&#xD;&#xA;            &lt;th width=&quot;15%&quot; class=&quot;Center&quot; valign=&quot;top&quot;&gt;19-29 Years&lt;/th&gt;&#xD;&#xA;            &lt;th width=&quot;15%&quot; class=&quot;Center&quot; valign=&quot;top&quot;&gt;30-39 Years&lt;/th&gt;&#xD;&#xA;            &lt;th width=&quot;15%&quot; class=&quot;Center&quot; valign=&quot;top&quot;&gt;40-49 Years&lt;/th&gt;&#xD;&#xA;            &lt;th width=&quot;15%&quot; class=&quot;Center&quot; valign=&quot;top&quot;&gt;50-64 Years&lt;/th&gt;&#xD;&#xA;            &lt;th width=&quot;15%&quot; class=&quot;Center&quot; valign=&quot;top&quot;&gt;65 Years +&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Health maintenance visit&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;&lt;strong&gt;&lt;em&gt;Annually for all ages&lt;/em&gt;&lt;/strong&gt;. Includes initial/interval history, age-appropriate physical exam; height, weight and body mass index (BMI) measurements; preventive screenings and counseling; assessment and administration of needed immunizations.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Oral health visit&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Promote dental health through regular oral hygiene practices, assessment by a dentist at least every 6 months, and timely management of dental disease.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; colspan=&quot;6&quot;&gt;Labs and Screenings&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;6&quot;&gt;&lt;em&gt;Cancer Screening&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Breast cancer: mammography&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;Annual clinical breast exam and self-examination instruction as appropriate. Mammography not routine except for patients at high risk. Accurate and detailed history and family history will identify risk factors.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annual clinical breast exam and self-examination instruction as appropriate. Annual mammography at discretion of clinician/patient.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annual clinical breast exam and self-examination instruction as appropriate. &lt;strong&gt;&lt;em&gt;Annual mammography&lt;/em&gt;&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annual clinical breast exam and self-examination instruction as appropriate. Mammography annually through age 69. Age 70+ at discretion of clinician/patient.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Cervical cancer (pelvic exam &amp;amp; Pap smear)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;First pap smear and pelvic exam by age 21 or earlier if sexually active. Every 2 years through age 29. When speculum testing is too traumatizing consider annual human papillomavirus (HPV) testing via vaginal swab.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;3&quot;&gt;Perform pap smear and pelvic exam &lt;em&gt;&lt;strong&gt;every 3 years&lt;/strong&gt;&lt;/em&gt;, depending on risk factors and clinician/patient discretion.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;May be omitted after age 65 if previous screenings were consistently normal.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Colorectal cancer&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;3&quot;&gt;Not routine except for patients at high risk. Risk factors include: diagnosis of a close relative; specific genetic syndromes; inflammatory bowel disease and noncancerous polyps. &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;Starting at age 50, fecal occult blood testing (FOBT) and sigmoidoscopy every 5 years &lt;strong&gt;OR&lt;/strong&gt; annual FOBT &lt;strong&gt;OR&lt;/strong&gt; colonoscopy every 10 years. Screening after age 80 at clinician/patient discretion.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Testicular and prostate cancer&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;Prostate cancer screening not routine. Clinical testicular exam at clinician's discretion.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Testing at clinician/patient's discretion considering risks/benefits of screening with prostate-specific antigen (PSA) blood test and/or digital rectal exam (DRE) for patients with risk factors (family history or African-American ancestry). Annual clinical testicular exam at clinician's discretion.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;Discuss risks and benefits of prostate cancer screening with specific PSA blood test and/or DRE with patients ages 50-75, based on presence of symptoms and at clinician/patient discretion. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Skin cancer&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Total skin examinations every 3 years between the ages of 20 and 39 and annually at age 40 and older, regardless of skin tone and color. Frequency at clinician discretion based on risk factors.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;6&quot;&gt;&lt;em&gt;Additional Recommended Screening&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;BMI&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Screen for overweight and eating disorders. Consult the Centers for Disease Control and Prevention's (CDC's) growth and BMI charts (&lt;a href=&quot;http://www.cdc.gov/nccdphp/dnpa/bmi/index.htm&quot; title=&quot;CDC Web site&quot; target=&quot;_blank&quot;&gt;www.cdc.gov/nccdphp/dnpa/bmi/index.htm&lt;/a&gt;). Ask about body image and diet patterns. &lt;strong&gt;&lt;em&gt;Counsel on benefits of physical activity and a healthy diet to maintain desirable weight for height. Offer more focused evaluation and intensive counseling for adults for BMI &amp;gt;30 kg/m&lt;sup&gt;2&lt;/sup&gt; to promote sustained weight loss&lt;/em&gt;&lt;/strong&gt;.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Hypertension&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;At every acute/non-acute medical encounter and &lt;strong&gt;&lt;em&gt;at least annually&lt;/em&gt;&lt;/strong&gt;.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Cholesterol&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;Every five years or at clinician's discretion.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;At clinician's discretion.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Diabetes (type 2)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Glycosylated hemoglobin (HgbA1c) or fasting plasma glucose screen every 3 years beginning at age 45. &lt;em&gt;&lt;strong&gt;At least every 5 years until age 45 if at high risk&lt;/strong&gt;&lt;/em&gt; (obesity, family history of diabetes, low high-density lipoprotein [HDL] cholesterol, high triglycerides, hypertension, sedentary; and for African, Hispanic, and Native Americans, Asian). &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;&lt;em&gt;Liver function&lt;/em&gt;&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;&lt;strong&gt;&lt;em&gt;Annually for hepatitis B carriers. At clinician's discretion after consideration of risk factors including long term prescription medication&lt;/em&gt;&lt;/strong&gt;. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;&lt;em&gt;Dysphagia &amp;amp; aspiration&lt;/em&gt;&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;&lt;em&gt;&lt;strong&gt;Chronic dysphagia and gastroesophageal reflux disease (GERD) are common in individuals with developmental disabilities (DD) and neuromuscular dysfunction. Assess initially and inquire about changes at annual physical&lt;/strong&gt;&lt;/em&gt;.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;&lt;em&gt;Cardiovascular disease&lt;/em&gt;&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;&lt;strong&gt;&lt;em&gt;Screen for cardiovascular diseases and malformations earlier and more regularly than the general population. Specific syndromes and neuroleptic medications may increase risk for cardiac disease&lt;/em&gt;&lt;/strong&gt;.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Osteoporosis&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;3&quot;&gt;Bone mineral density (BMD) testing &lt;strong&gt;&lt;em&gt;starting at age 19&lt;/em&gt;&lt;/strong&gt; when risk factors are present: long term polypharmacy, especially antipsychotic and anti-seizure medications; mobility impairments; hypothyroid; post-menopausal women. Periodicity of screening at clinician's discretion. Annually counsel about preventive measures including dietary calcium and vitamin D intake, weight-bearing exercise, and not smoking.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;Provide BMD testing. Counsel elderly patients about specific measures to prevent falls.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;em&gt;&lt;strong&gt;Eye examination&lt;/strong&gt;&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;&lt;em&gt;&lt;strong&gt;ALL, including those with legal or total blindness, should be under an active vision care plan and eye examination schedule based on recommendations from an eye specialist (ophthalmologist or optometrist.)&lt;/strong&gt;&lt;/em&gt; Refer to eye specialist if new ocular signs and/or symptoms develop, including changes in vision/behavior. &lt;em&gt;&lt;strong&gt;Annual comprehensive eye exam for patients with diabetes.&lt;/strong&gt;&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Glaucoma assessment &lt;strong&gt;&lt;em&gt;(by ophthalmologist or optometrist)&lt;/em&gt;&lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;Glaucoma assessment at least once by &lt;strong&gt;&lt;em&gt;age 22&lt;/em&gt;&lt;/strong&gt;. Follow up exam every &lt;em&gt;&lt;strong&gt;2-3 years&lt;/strong&gt;&lt;/em&gt;; more frequently for higher risk patients&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;3&quot;&gt;Glaucoma assessment&lt;em&gt;&lt;strong&gt; every 1-2 years&lt;/strong&gt;&lt;/em&gt;, with more frequent eye exams for higher risk patients.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Hearing assessment&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;&lt;em&gt;&lt;strong&gt;Assess for hearing changes annually&lt;/strong&gt;&lt;/em&gt; and refer to audiologist for a full screen as needed. Re-evaluate if hearing problem is reported or a change in behavior is noted.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; colspan=&quot;6&quot;&gt;Infectious Disease Screening&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Sexually transmitted infections&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;For chlamydia and gonorrhea: Sexually active patients under age 25: Screen annually. Patients age 25 and over: Screen annually, if at risk.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Human immunodeficiency virus (HIV)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Periodic testing if at risk due to sexual or drug behaviors, or who are pregnant.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;em&gt;&lt;strong&gt;Hepatitis B&lt;/strong&gt;&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Periodic testing if risk factors present.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Hepatitis C&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Periodic testing of all patients at high risk. Risk factors include: illicit injection use; receipt of blood product for clotting problems before 1987 and/or receipt of a blood transfusion or solid organ transplant before July, 1992 (if not previously tested); long term kidney dialysis; evidence of liver disease; a tattoo or body piercing by non-sterile needle; risky sex practices.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Tuberculosis (TB)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Tuberculin skin testing &lt;em&gt;&lt;strong&gt;every 1-2 years when risk factors present&lt;/strong&gt;&lt;/em&gt;. Risk factors include residents or employees of congregate setting, those who attend adult day programs, who rely on mass transit, or who are in close contact with persons known or suspected to have TB.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; colspan=&quot;6&quot;&gt;Immunizations&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Influenza&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annually&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annually&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annually&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annually&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Annually&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Pneumococcal&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&lt;strong&gt;&lt;em&gt;Once&lt;/em&gt;&lt;/strong&gt; and a booster at age 65. Booster after 5 years if chronic renal failure; sickle cell disease or splenectomy; immunocompromised&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Once, even if vaccinated before&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Hepatitis B&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;&lt;strong&gt;&lt;em&gt;3 dose series once&lt;/em&gt;&lt;/strong&gt; (dose #1 now, #2 1 month later, and #3 approximately 5 months after #2). &lt;em&gt;&lt;strong&gt;Reevaluate antibody status every 5 years.&lt;/strong&gt;&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Hepatitis A&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;2 doses if at risk and not previously immunized.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Tetanus, diphtheria, pertussis (TdaP)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;For adults &amp;lt; 65 years of age not previously vaccinated with Td: 1 dose of Tdap, followed by 2 doses of Td. Td booster every 10 years. For adults &amp;lt; 65 years of age who have not previously received a dose of Tdap, Tdap should replace a single dose of Td. Three doses if not previously immunized. Td booster every 10 years.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Measles, mumps, and rubella (MMR)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;One dose if born after 1957 and no documentation of vaccination and no laboratory evidence of immunity to measles, mumps and rubella. Two doses, 28 days after first does if risk factors are present.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Human papillomavirus (HPV) vaccine**&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Three doses for unvaccinated adults age 26 and under, &lt;em&gt;&lt;strong&gt;males and females&lt;/strong&gt;&lt;/em&gt;.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Varicella (chicken pox)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;2 doses recommended for those who do not have documentation of age-appropriate immunization or a reliable history of chicken pox (varicella).&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Zoster (shingles) vaccine**&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;4&quot;&gt;&amp;nbsp;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;&lt;em&gt;Once&lt;/em&gt;&lt;/strong&gt; after age 60, not for those with weak immune systems.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; colspan=&quot;6&quot;&gt;Mental and Behavioral Health&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Depression&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;&lt;em&gt;&lt;strong&gt;Screen annually for sleep, appetite disturbance, weight loss, general agitation&lt;/strong&gt;&lt;/em&gt;.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Dementia&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;2&quot;&gt;Monitor for problems performing daily activities.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;3&quot;&gt;&lt;em&gt;&lt;strong&gt;In persons with Down syndrome, annual screen after age 40.&lt;/strong&gt;&lt;/em&gt;&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;6&quot;&gt;&lt;strong&gt;For Persons with Down Syndrome&lt;/strong&gt; (in addition to the above recommendations)&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Thyroid function test&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Every 3 years (sensitive thyroid stimulating hormone [TSH]).&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Cervical spine X-ray&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Obtain baseline as adult to rule out atlanto-axial instability. Recommend repeat if symptomatic, or 30 years from baseline.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Echocardiogram&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Obtain baseline if no records of cardiac function are available.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot; colspan=&quot;6&quot;&gt;General Counseling and Guidance&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Prevention counseling&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Annually counsel regarding prevention of accidents related to falls, fire/burns, choking and screen for at-risk sexual behavior.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Abuse or neglect&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Annually monitor for behavioral signs of abuse and neglect.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Preconception counseling&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;As appropriate, including genetic counseling, folic acid supplementation, discussion of parenting capability.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Menopause management&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;At an appropriate age, counsel women on the changes that occur at menopause and their options for the symptom management.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Healthy lifestyle&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot; colspan=&quot;5&quot;&gt;Annually counsel regarding diet/nutrition, incorporating regular physical activity into daily routines, substance abuse.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;**Vaccines are recommended, but may not be covered by MassHealth or Medicare in all cases.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Preparation for an Examination&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Many adults can be helped to feel more comfortable at a medical visit if they feel adequately prepared for the event. Family or support staff can be encouraged to introduce unfamiliar items such as a stethoscope or a blood pressure cuff at home to allow the instrument to become more familiar and facilitate cooperation during an exam.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Prepare patients for exam procedures by explaining them well or allowing patients with sensory impairments to explore the instruments that are about to be used. Performing simple examinations in an office or quiet waiting room may reduce a person's anxiety.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;If someone is particularly anxious or an invasive screening procedure is necessary, the clinician might consider sedation prior to the appointment. In some cases, multiple procedures can be performed while the patient is sedated (dental work, or routine blood work, for example) to reduce the number of times a person is exposed to the risks of sedation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Communication&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;First, direct your questions to the patient. If communication is a problem, clinicians may have to rely on a family member or support staff to provide information relating to signs or symptoms of health concerns. Questions regarding changes in the individual's behavior and adaptive function can bring underlying physical and mental health issues to light.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The recommendations are based on the &lt;a href=&quot;http://www.mhqp.org/&quot; title=&quot;Massachusetts Health Quality Partnership (MHQP) Web site&quot;&gt;Massachusetts Health Quality Partnership (MHQP)&lt;/a&gt; Adult Preventive Care Recommendations 2010/11, Consensus Guidelines for primary health care of adults with developmental disabilities, Canadian Family Physician, Volume 57, 2011, and US Preventive Services Task Force Guidelines, American Association of Intellectual and Developmental Disabilities, 2011.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Appropriate preventive healthcare for adults with intellectual disability (mental retardation)&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;No potential harms were identified at the time of development.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;With the presentation of these recommendations, the Advisory Committee does not intend to imply that adults with intellectual and developmental disabilities all have similar health needs or that clinicians should not continue to use their clinical judgment and seek additional consultation when necessary. The Advisory Committee sees these recommendations as one of a number of steps towards ensuring that every adult with intellectual and developmental disabilities receives the most appropriate health care as an individual.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An implementation strategy was not provided.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Chart Documentation/Checklists/Forms" /><FieldValue Value="Patient Resources" /><FieldValue Value="Quick Reference Guides/Physician Guides" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Massachusetts Department of Developmental Services. Massachusetts Department of Developmental Services adult screening recommendations 2012. Boston (MA): Massachusetts Department of Developmental Services; 2012. 2 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The recommendations are based on the &lt;a href=&quot;http://www.mhqp.org/&quot; title=&quot;Massachusetts Health Quality Partnership (MHQP) Web site&quot;&gt;Massachusetts Health Quality Partnership (MHQP)&lt;/a&gt; Adult Preventive Care Recommendations 2010/11, Consensus Guidelines for primary health care of adults with developmental disabilities, Canadian Family Physician, Volume 57, 2011, and US Preventive Services Task Force Guidelines, American Association of Intellectual and Developmental Disabilities, 2011.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2003 Sep 19 (revised 2012)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Massachusetts Department of Developmental Services - State/Local Government Agency [U.S.]" /><FieldValue Value="University of Massachusetts Medical School's Center for Developmental Disabilities Evaluation and Research - Academic Institution" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Massachusetts Department of Developmental Services&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Massachusetts Department of Mental Retardation Preventive Health Standards Advisory Committee&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Advisory Committee Members&lt;/em&gt;: Victor Acquista, MD; Norberto Alvarez, MD; Bob Baldor, MD; Allen Crocker, MD; Marc Emmerich, MD; Warren Ferguson, MD; Jim Gleason, PT; Adria Hodas, RN NP; Elizabeth King, RN NP; Leo McKenna, PharmD; Barbara Pilarcik, RN; Julie Lufkin Purtz, RN NP; Van R. Silka, MD; Carol Walsh RNC, MPH; Susan Weiner, OT&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Guideline Revision Members&lt;/em&gt;: Sharon Oxx, RN, CDDN; Alexandra Bonardi, OTR/L, MHA; Courtney Noblett, MPA; Bob Baldor, MD&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Massachusetts Department of Developmental Services. Massachusetts Department of Mental Retardation health screening recommendations. Boston (MA): Massachusetts Department of Developmental Services; 2007. 2 p.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Print copies: Available from the University of Massachusetts Medical School, Center for Developmental Disabilities Evaluation and Research, 200 Trapelo Road, Waltham, MA 02452; Phone: (781) 642-0283; Fax: (781) 642-0162.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Preventive health recommendations for adults with mental retardation. Guidelines for community practitioners. Boston (MA): Massachusetts Department of Developmental Services and University of Massachusetts Medical School Center for Development Disabilities Evaluation and Research; 2012. 2 p. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Massachusetts Department of Developmental Services annual health screening recommendations. Checklist. Boston (MA): Massachusetts Department of Developmental Services and University of Massachusetts Medical School Center for Development Disabilities Evaluation and Research; 2012. 1 p. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from the University of Massachusetts Medical School, Center for Developmental Disabilities Evaluation and Research, 200 Trapelo Road, Waltham, MA 02452; Phone: (781) 642-0283; Fax: (781) 642-0162.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following is available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Massachusetts Department of Mental Retardation annual health screening recommendations. Boston (MA): Massachusetts Department of Developmental Services and University of Massachusetts Medical School Center for Development Disabilities Evaluation and Research; 2012. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from the University of Massachusetts Medical School, Center for Developmental Disabilities Evaluation and Research, 200 Trapelo Road, Waltham, MA 02452; Phone: (781) 642-0283; Fax: (781) 642-0162.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This summary was prepared by ECRI on January 29, 2004. The information was verified by the guideline developer on February 26, 2004. This summary was updated by ECRI Institute on April 21, 2009. The updated information was verified by the guideline developer on May 12, 2009. This summary was updated by ECRI Institute on September 10, 2012. The updated information was verified by the guideline developer on November 2, 2012.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Refer to the Center for Developmental Disabilities Education and Research (E.K. Shriver Center for Mental Retardation) for permission to reproduce guidelines.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
